ArticleBlood advances2025

Efficacy of MRD-triggered anti-CD20 retreatment in patients with high-risk chronic lymphocytic leukemia: a case series.

Ellinor Goergen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.